The objective of this course is to provide an overview to technical professionals, particularly those in Research & Development and Regulatory Affairs, on the general legal requirements to bring a pharmaceutical product to market – whether it is the creation of a new product, or import/export of a product to a new market – and maintaining it afterwards.
This course will discuss medical devices in major international reference environments and select countries in Asia, medical device definitions and classifications. The course will discuss the major pre-marketing regulatory challenges and potential solutions in key Asian markets.
Advanced products such as combination products are interpreted differently by different agencies, and there tends to be more disparity among Asian countries compared to more mature Western agencies. This course will discuss some of the challenges with such advanced products.
• Introduction to RA – what is the role of RA
• Introduction to major global reference regulations and harmonizations:
• Overview of regulatory environment in major Asian reference countries:
o Future trends in regulatory development \
• Classification of drugs and formulations
• Pre-market requirements
• Authorization procedures for drug products
• Quality systems and regulatory inspection process
• Post-market requirements and compliance
• Advanced products:
o Orphan drugs
o Named-patient drugs
Upon completion of this course the attendees will be able to:
1. Understand major global reference regulations and harmonization efforts for pharmaceuticals
2. Understand regulatory environment in key Asian markets for pharmaceuticals
3. Understand general pre-market and post-market requirements
4. Understand the legal logics behind the definition and regulation of advanced products
Fees & Funding
Please enquire below for course fees and financial grants: